ID   Me-116
AC   CVCL_C598
DR   ESTDAB; ESTDAB-122
DR   Wikidata; Q54904900
RX   PubMed=15592718;
CC   HLA typing: A*02:01,01:01; B*52:01:01,18:01; DPB1*03:01,13:01; DQB1*03:03:02,02:01; DRB1*03:01:01,07:01 (PubMed=15592718).
ST   Source(s): ESTDAB=ESTDAB-122
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   FGA: 21,22
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
RX   PubMed=15592718; DOI=10.1007/s00262-004-0561-5; PMCID=PMC11032966;
RA   Rodriguez, Teresa
RA   Mendez, Rosa
RA   Roberts, Chrissy H.
RA   Ruiz-Cabello Osuna, Francisco
RA   Dodi, I. Anthony
RA   Lopez-Nevot, Miguel Angel
RA   Paco, Laura
RA   Maleno, Isabel
RA   Marsh, Steven G.E.
RA   Pawelec, Graham
RA   Garrido, Federico
RT   "High frequency of homozygosity of the HLA region in melanoma cell
RT   lines reveals a pattern compatible with extensive loss of
RT   heterozygosity.";
RL   Cancer Immunol. Immunother. 54:141-148(2005).
//